Antigen Express, Inc.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 7248
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 3164

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9289487 II-key/antigenic epitope hybrid peptide vaccinesJan 11, 05Mar 22, 16[A61K]
8889143 Ii-key/HER-2/neu hybrid cancer vaccineDec 10, 09Nov 18, 14[A61K]
8815249 Ii-key/antigenic epitope hybrid peptide vaccinesJul 26, 10Aug 26, 14[A61K]
8748130 Human papillomavirus / Ii-Key hybrids and methods of useSep 01, 09Jun 10, 14[A61K, C12N]
7935350 Ii-key/Her-2/neu hybrid cancer vaccineDec 13, 07May 03, 11[A61K, C07K]
7205274 Hybrid peptides modulate the immune responseJul 17, 02Apr 17, 07[A61K]
7179645 Ii-Key/antigenic epitope hybrid peptide vaccinesSep 24, 02Feb 20, 07[C12N]
6432409 Hybrid peptides modulate the immune responseSep 14, 99Aug 13, 02[A61K]
6368855 MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expressionDec 04, 98Apr 09, 02[C12N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0093,402 Ii-KEY/HER-2/NEU HYBRID CANCER VACCINEAbandonedOct 23, 14Apr 02, 15[A61K]
2010/0310,591 Ii-KEY HYBRID PEPTIDES THAT MODULATE THE IMMUNE RESPONSE TO INFLUENZAAbandonedJan 28, 10Dec 09, 10[A61K, C12N, C40B, C07K]
2010/0255,019 Ii-KEY/HER-2/NEU HYBRID CANCER VACCINEAbandonedDec 21, 09Oct 07, 10[A61K, A61P]
7541334 Hybrid peptides modulate the immune responseExpiredApr 04, 07Jun 02, 09[A61K]
2009/0060,889 Ii-RNAi involved Ii suppression in cancer immunotherapyAbandonedMar 10, 08Mar 05, 09[A61K, C12N, A61P]
2008/0305,122 Ii-Key/antigenic epitope hybrid peptide vaccinesAbandonedFeb 16, 07Dec 11, 08[A61K, C12N, C07K]
2008/0095,798 Ii-key enhanced vaccine potencyAbandonedOct 18, 06Apr 24, 08[A61K]
2006/0008,448 Inhibition of li expression in mammalian cellsAbandonedNov 29, 04Jan 12, 06[A61K]
2003/0235,594 Ii-Key/antigenic epitope hybrid peptide vaccinesAbandonedSep 17, 02Dec 25, 03[A61K, C07H, C12P, C12N, C07K]
2003/0198,626 Inhibition of Ii expression in mammalian cellsAbandonedApr 22, 02Oct 23, 03[A61K, C07H, C12P, C12N]
2003/0054,365 MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expressionAbandonedJan 22, 02Mar 20, 03[C07H, C12Q, C07F, C07D]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.